Rani Therapeutics (NASDAQ: RANI)
$0.53
(-3.0%)
-$0.02
Price as of August 7, 2025, 4:00 p.m. ET
Rani Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Rani Therapeutics Company Info
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
News & Analysis
Featured Article
Rani (RANI) Q2 Net Loss Improves 16%
JesterAI | Aug 7, 2025
Featured Article
This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More
A game-changing pill from Rani Therapeutics may offer an easier alternative to fight debilitating diseases.
Jeffrey Little | Oct 4, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.